Skip to main content
Company profilei-mabbiopharma.com ↗

I-Mab Biopharma

I-Mab is a U.S.-based global biotechnology company focused on developing precision immuno-oncology agents for cancer treatment.

Biotechnology
Explore the company ↓Explore its lists ↓
Headquarters
Rockville, Maryland, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range
11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded
2016Source: RevenueBaseRetrieved October 13, 2026
Published list appearances
13 supported appearances ↗Source: RevenueBase lists
The company at a glance

What does I-Mab Biopharma do?

The company’s pipeline is led by givastomig, a bispecific antibody designed to treat Claudin 18.2-positive gastric cancers. Givastomig is being developed for first-line metastatic gastric cancer, with potential applications in other solid tumors.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Precision immuno-oncology agent development

The company develops precision immuno-oncology agents for cancer treatment.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEWI-Mab Biopharma listed #7 on Biotherapeutics companies, September 18, 2026Open the published source list.
I-Mab Biopharma

#7 Biotherapeutics companies

Snapshot: September 18, 2026

Download SVG
View live list ↗

Company information

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026, September 21, 2026, September 27, 2026 and October 8, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗
Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →